Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer

SIMPLE SUMMARY: Triple-negative breast cancers (TNBCs) are mainly treated with standard chemotherapies. Combined therapies have been demonstrated as a promising treatment strategy in clinics. The aim of this study was to develop a new formulation of combined chemotherapies facilitated with a targete...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Yingnan, Zhang, Ya, Ngo, Hanh Giai, Guan, Jia-Shiung, Chen, Kai, Wang, Qing, Singh, Ajeet Pal, Xu, Yuanxin, Zhou, Lufang, Yang, Eddy S., Liu, Xiaoguang (Margaret)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345094/
https://www.ncbi.nlm.nih.gov/pubmed/34359650
http://dx.doi.org/10.3390/cancers13153749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345094/
https://www.ncbi.nlm.nih.gov/pubmed/34359650
http://dx.doi.org/10.3390/cancers13153749

Ejemplares similares